Motif Bio up 15% premarket ahead of Inclaprim presentations

Apr. 04, 2019 9:21 AM ETMotif Bio plc (MTFB)By: Douglas W. House, SA News Editor
  • Nano cap Motif Bio plc (NASDAQ:MTFB) perks up 15% premarket on average volume in apparent response to upcoming abstracts on iclaprim to be presented at ECCMID in Amsterdam starting next Saturday, April 13.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.